Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Incannex Healthcare (IXHL) EBITDA (2023 - 2025)

Historic EBITDA for Incannex Healthcare (IXHL) over the last 3 years, with Q4 2025 value amounting to $6.8 million.

  • Incannex Healthcare's EBITDA rose 792.64% to $6.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$34.7 million, marking a year-over-year decrease of 19464.26%. This contributed to the annual value of -$46.7 million for FY2025, which is 15194.22% down from last year.
  • Per Incannex Healthcare's latest filing, its EBITDA stood at $6.8 million for Q4 2025, which was up 792.64% from -$6.2 million recorded in Q3 2025.
  • Over the past 5 years, Incannex Healthcare's EBITDA peaked at $6.8 million during Q4 2025, and registered a low of -$31.3 million during Q2 2025.
  • Its 3-year average for EBITDA is -$5.2 million, with a median of -$4.7 million in 2023.
  • Per our database at Business Quant, Incannex Healthcare's EBITDA surged by 24622.16% in 2024 and then tumbled by 40945.4% in 2025.
  • Quarter analysis of 3 years shows Incannex Healthcare's EBITDA stood at -$4.3 million in 2023, then surged by 246.22% to $6.3 million in 2024, then increased by 7.93% to $6.8 million in 2025.
  • Its EBITDA stands at $6.8 million for Q4 2025, versus -$6.2 million for Q3 2025 and -$31.3 million for Q2 2025.